The gut microbiome and liver cancer: mechanisms and clinical translation.
The gut microbiome and liver cancer: mechanisms and clinical translation.
复制标题
DOI:
10.1038/nrgastro.2017.72
复制
发表时间:
2017-09
期刊:
影响因子:
--
通讯作者:
Schwabe RF
中科院分区:
文献类型:
--
作者:
Yu LX;Schwabe RF
Hepatocellular carcinoma (HCC) is the third leading cause of worldwide cancer mortality. HCC almost exclusively develops in patients with chronic liver disease, driven by a vicious cycle of liver injury, inflammation and regeneration that typically spans decades. Increasing evidence points towards a key role of the bacterial microbiome in promoting the progression of liver disease and the development of HCC. Here, we will review mechanisms by which the gut microbiota promotes hepatocarcinogenesis, focusing on the leaky gut, bacterial dysbiosis, microbe-associated molecular patterns and bacterial metabolites as key pathways that drive cancer-promoting liver inflammation, fibrosis and genotoxicity. On the basis of accumulating evidence from preclinical studies, we propose the gut-microbiota–liver axis as a promising target for the simultaneous prevention of chronic liver disease progression and HCC development in patients with advanced liver disease. We will review in detail therapeutic modalities and discuss clinical settings in which targeting the gut-microbiota–liver axis for the prevention of disease progression and HCC development seems promising.
登录
查看更多内容
影响因子:
120.7
作者:
Chen, CJ;Yang, HI;Iloeje, UH
通讯作者:
Iloeje, UH
影响因子:
29.4
作者:
Chen P;Torralba M;Tan J;Embree M;Zengler K;Stärkel P;van Pijkeren JP;DePew J;Loomba R;Ho SB;Bajaj JS;Mutlu EA;Keshavarzian A;Tsukamoto H;Nelson KE;Fouts DE;Schnabl B
通讯作者:
Schnabl B
影响因子:
7.7
作者:
Cani, Patrice D.;Amar, Jacques;Burcelin, Remy
通讯作者:
Burcelin, Remy
影响因子:
9.4
作者:
Bert, Frederic;Johnson, James R.;Nicolas-Chanoine, Marie-Helene
通讯作者:
Nicolas-Chanoine, Marie-Helene
DOI:
10.1073/pnas.1424775112
发表时间:
2015-02-17
影响因子:
11.1
作者:
Chou, Han-Hsuan;Chien, Wei-Hung;Chen, Ding-Shinn
通讯作者:
Chen, Ding-Shinn